Search Results - "Alharf, Adel"

Top 10 most used drugs in the Kingdom of Saudi Arabia 2010–2015 by AlKhamees, Osama A., AlNemer, Khaled A., Bin Maneea, Mohammed W., AlSugair, Faisal A., AlEnizi, Bassam H., Alharf, Adel A.

“…Medications usage has become a significant part of contemporary life. Many studies indicate that there is an excessive use and a considerable waste of…”
Get full text

Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials by Alghamdi, Jahad, Alqadi, Abdulziz, Alharf, Adel, Almuzzaini, Bader, Mahmud, Azra, Barhoumi, Tlili, Badreldin, Hisham A, Alaamery, Manal, Padmanabhan, Sandosh

“…Purpose To investigate the blood pressure (BP)–lowering effects of statins by conducting a systematic review and meta-analysis of placebo-randomized controlled…”
Get full text

Saudi Vigilance Program: Challenges and lessons learned by Alharf, Adel, Alqahtani, Nasser, Saeed, Ghazi, Alshahrani, Ali, Alshahrani, Mubarak, Aljasser, Nasser, Alquwaizani, Mohammed, Bawazir, Saleh

“…Pharmacovigilance is vital to public health. Adopting a robust spontaneous reporting system for adverse drug events can counteract most hazards that arise from…”
Get full text

National medicines policy development, Saudi Arabia by Almoteiry, Khalid, Alharf, Adel, Al Hammad, Bandar, Aljuffali, Ibrahim, Al-Azemi, Nahar, Al-Ghaith, Taghred, Alhomidi, Shahad, Alshehri, Ahlam, Seiter, Andreas, Herbst, Christopher, Pisani, Elizabeth

“…Les médicaments sont au coeur de tout système de santé. L'Organisation mondiale de la Santé recommande aux pays d'élaborer des politiques pharmaceutiques…”
Get full text

National medicines policy development, Saudi Arabia/[phrase omitted]/[phrase omitted]/ Elaboration des politiques pharmaceutiques nationales en Arabie saoudite/[phrase omitted]/ Desarrollo de la politica nacional de medicamentos en Arabia Saudita by Almoteiry, Khalid, Alharf, Adel, Hammad, Bandar Al, Aljuffali, Ibrahim, Azemi, Nahar Al, Ghaith, Taghred Al, Alhomidi, Shahad, Alshehri, Ahlam, Seiter, Andreas, Herbst, Christopher, Pisani, Elizabeth

“…Medicines are at the core of every health system. The World Health Organization recommends countries develop national medicines policies that guide production,…”
Get full text

Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP) by Ammari, Maha Al, Almuzzaini, Bader, Al Sulaiman, Khalid, AlBalwi, Mohammed, Sultana, Khizra, Alabdulkareem, Ibrahim B., Almakhlafi, Nada S., Humoud, Anoud Al, Waheeby, Mohammed, Balla, Munee, Shehri, Asma Al, Alharf, Adel, Alghamdi, Jahad

“…Background Warfarin is an oral anticoagulant commonly used for treatment and prophylaxis against thromboembolic events. Warfarins’s narrow therapeutic index…”
Get full text

Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example by Alnafisah, Alhanouf Yousef, Alkhalidi, Ahmed Fawaz, Aljohani, Hanin, Almutairi, Manal, Alharf, Adel, Alkofide, Hadeel

“…In response to the COVID-19 pandemic, the World Health Organization (WHO) developed a set of outcome measures for trials primarily aimed at hospitalised…”
Get full text

The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities by Fernandes, Eduardo Agostinho Freitas, van Oudtshoorn, Joy, Tam, Andrew, González, Liliana Carolina Arévalo, Aurela, Erwin Guzmán, Potthast, Henrike, Mettke, Katalina, Kuribayashi, Ryosuke, Shimojo, Kohei, Kasuga, Miho, Morales, Lázaro, Rodríguez, Zulema, Jones, Ben, Ahn, Choongyul, Yun, Eunju, Kim, So Hee, Rodrigues, Clare, Tiong, Toh, Crane, Christopher, Walther, Chantal, Roost, Matthias S, Chen, Tzu-Ling, Hsu, Li-Feng, Braddy, April C, García-Arieta, Alfredo, Abalos, Ivana, Divinsky, Milly, Alsuwyeh, Abdulaziz, Alzenaidy, Bader, Alharf, Adel

“…Bioequivalence (BE) studies are considered the standard for demonstrating that the performance of a generic drug product in the human body is sufficiently…”
Get full text

Prevalence of and clinical characteristics associated with microalbuminuria in hypertension by Alharf, Adel Abdullah

“…Cardiovascular disease is the leading cause of mortality. As blood pressure is one of the most important risk factors for cardiovascular disease, effective…”
Get full text